Effect of various 6-hydroxydopamine treatments during development on growth and ingestive behavior

@article{Breese1975EffectOV,
  title={Effect of various 6-hydroxydopamine treatments during development on growth and ingestive behavior},
  author={George R. Breese and Ronald D. Smith and Barrett R. Cooper},
  journal={Pharmacology Biochemistry and Behavior},
  year={1975},
  volume={3},
  pages={1097-1106},
  url={https://api.semanticscholar.org/CorpusID:20698213}
}

Dopaminergic but not noradrenergic mediation of hyperactivity and performance deficits in the developing rat pup

It is suggested that preferential reduction of brain DA in the developing rat pup increases motor activity and impairs habituation of activity during the stage of behavioral arousal in week 3 of postnatal life.

Developmental characteristics of brain catecholamines and tyrosine hydroxylase in the rat: effects of 6‐hydroxydopamine

The concentrations of noradrenaline, dopamine or tyrosine hydroxylase in rats that received 6‐hydroxydopamine at 7 or 14 days of age remained markedly reduced when determined at adulthood, indicating that fibres did not continue to develop after the administration of this compound.

Deficits in Feeding Behavior after Intraventricular Injection of 6-Hydroxydopamine in Rats

After treatment with the monoamine oxidase inhibitor pargyline, 6-hydroxydopamine produced no further norepinephrine depletion but increased the dopamnine depletion to 95 percent and produced complete aphagia.